Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Nov 2022 – 20 Aug 2026, limited by HSBC Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | HSBC Value Fund | Nifty 500 |
|---|---|---|
| 28 Nov 2022 | ₹100.00 | ₹100.00 |
| 21 Mar 2023 | ₹88.58 | ₹91.30 |
| 13 Jul 2023 | ₹101.00 | ₹105.32 |
| 03 Nov 2023 | ₹110.85 | ₹107.71 |
| 25 Feb 2024 | ₹125.32 | ₹128.69 |
| 17 Jun 2024 | ₹143.44 | ₹140.74 |
| 09 Oct 2024 | ₹148.80 | ₹149.51 |
| 30 Jan 2025 | ₹122.42 | ₹134.93 |
| 23 May 2025 | ₹130.57 | ₹144.33 |
| 14 Sep 2025 | ₹134.03 | ₹146.92 |
| 05 Jan 2026 | ₹141.84 | ₹152.42 |
| 29 Apr 2026 | ₹126.70 | ₹144.90 |
| 20 Aug 2026 | ₹129.62 | ₹148.96 |
| Metric | HSBC · Regular · IDCW NAV ₹50.27 Very High risk ★★☆☆☆ | Category median Value Fund · 27 funds |
|---|---|---|
| -4.85% | +1.55% | |
| +7.13% | +10.75% | |
| — | +10.54% | |
| — | +7.06% | |
| +7.21% | +8.32% | |
| +3.44% | — | |
| +9.90% | +10.45% | |
| — | +8.52% | |
| — | +6.67% | |
| Risk | ||
| 17.94% | 15.42% | |
| 0.04 | 0.30 | |
| 0.04 | 0.39 | |
| -27.35% | -47.99% | |
| Nifty 500 | — | |
| -4.84% | -0.99% | |
| 1.12 | 0.95 | |
| 103.8% | 99.4% | |
| 138.9% | 105.5% | |
| 1.86% | 2.35% | |
| ₹14,682Cr | ₹1,405Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 30% | 40% | |
| Mayank Chaturvedi | — | |
| 28 Nov 2022 | — | |
| 81 | — | |
| 31.7% | — | |
| 1.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.